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NARCOLEPSY IS A CLINICALLY HETEROGENEOUS 
CONDITION.1,2 NEXT TO THE CORE FEATURES OF EX-
CESSIVE DAYTIME SLEEPINESS AND CATAPLEXY, there 
is a varying number of additional symptoms. Besides sleep-re-
lated symptoms, such as sleep paralysis, hypnagogic hallucina-
tions and fragmented nocturnal sleep, non-sleep symptoms are 
often encountered. One of the more prominent of those is the 
increase in body weight in many patients. Already in the 1930s, 
Daniels reported that 57% of his patients with narcolepsy were 
overweight or obese.3 Recently, a number of epidemiologic 
studies showed a clear increase in body mass index (BMI) in 
narcoleptic patients compared with the general population,4-6 
with a preferential storage of fat in the abdominal compart-
ment.6 Several explanations for the weight gain have been put 
forward. Although the psychoanalytic theory of weight gain 
due to “substitutive oral activity” held for a while,7 recent dis-
coveries into the biologic basis of narcolepsy provided more 
founded mechanisms.
Most cases of narcolepsy with cataplexy are caused by a de-
ficiency in hypocretin (orexin) neurotransmission.8,9 The hypo-
cretin neurons are located in the perifornical area of the lateral 
hypothalamus and are involved not only in the regulation of 
sleep, but in endocrine and autonomic regulation as well.10 The 
weight gain in narcolepsy could be caused by changes in energy 
expenditure due to excessive sleepiness, changes in basal meta-
bolic rate,11,12 or endocrine disturbances.13,14 Excessive daytime 
sleepiness is not likely to be a major factor, as patients with 
narcolepsy have a significantly higher BMI than do patients 
with idiopathic hypersomnia.6 Interestingly, recent studies have 
shown that the hypocretin system may also be active in the 
psychiatric domain.15,16 This, in combination with the known 
stimulatory effect of hypocretin on food intake,17 raises the pos-
sibility that eating disorders may be present in narcolepsy.
Although a controlled diary study showed no differences 
in total caloric intake between patients with narcolepsy and 
controls,18 there have been some reports on symptoms of eat-
ing disorders. Kotagal et al found a history of binge eating in 
5 out of 31 children with narcolepsy.19 Recently, Chabas et al 
reported a mild eating disorder, classified as eating disorder not 
otherwise specified (EDNOS), in 6 patients with narcolepsy-
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cataplexy.12 Besides this study, no systematic studies on the 
prevalence of (symptoms of) eating disorders have been carried 
out. Furthermore, the influence of an increased body weight per 
se on such symptoms remains unknown in narcolepsy.
To determine whether eating disorders (at the diagnostic as 
well as the symptom level) are indeed more prevalent in narco-
lepsy, we performed a large cross-sectional case control study 
comparing 60 patients with narcolepsy-cataplexy with healthy 
controls from the general population. In addition, to study the 
influence of overweight, we performed a separate study in 
which 32 patients with narcolepsy were compared with 32 con-
trols who were also matched for BMI.
MethoDs
General study Design
We conducted 2 separate cross-sectional case-control stud-
ies. In study I, we compared symptoms of eating disorders in 
60 patients with narcolepsy-cataplexy with 120 age- and sex-
matched controls taken from a large population-based study. In 
study II, 32 patients with narcolepsy were compared (using an 
additional diagnostic instrument) with 32 specifically recruited 
controls, matched not only for age and sex, but also for BMI. 
This study was conducted according to the guidelines of the 
medical ethics committee of the Radboud University Nijmegen 
Medical Center. All subjects gave informed consent prior to en-
tering the study.
participants
Narcoleptic patients were recruited from the outpatient clin-
ics of Sleep-Wake Center ‘Kempenhaeghe’ (Heeze, The Neth-
erlands) and the Department of Neurology, Leiden University 
Medical Center (Leiden, The Netherlands). All patients fulfilled 
the ICSD-2 diagnostic criteria of narcolepsy with cataplexy.20 
All were HLA-DQB1*0602 positive, and multiple sleep laten-
cy testing showed a mean sleep latency of less than 8 minutes 
as well as 2 or more sleep-onset rapid eye movement periods. 
In only a minority of patients, cerebral spinal fluid hypocretin-1 
measurements were performed.9 Other sleep disturbances, such 
as sleep-related breathing disorders, were excluded as the cause 
for the excessive daytime sleepiness.
In study I, 60 narcoleptic patients were compared with 120 
control subjects. Controls were randomly taken from the cross-
sectional population-based Nijmegen-Health-Area-2 study, in 
which psychiatric symptoms were assessed in 368 people from 
the Dutch population.21 Controls were matched for age, sex, and 
urban environment (living in residential area with less or more 
than 100.000 inhabitants).
In study II, 32 narcoleptic patients were compared with 32 
controls, recruited by advertisement in a local newspaper. Here, 
subjects were also matched for BMI, as BMI has been shown to 
influence eating attitudes and behavior.22-24
Measurements
Symptoms of eating disorders were assessed using chapter 
8 and 9 of the Schedules for Clinical Assessment in Neuropsy-
chiatry (SCAN) version 2.1. The SCAN consists of a semistruc-
tured interview that incorporates the Present State Examination, 
version 10.25 The SCAN is a validated diagnostic instrument 
that is widely endorsed.25-28 Both the patients and the popula-
tion controls were interviewed by trained and certified SCAN 
investigators. From the SCAN data, symptoms of eating dis-
orders can be assessed on the item level. In addition, it is pos-
sible to classify symptoms into the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition (DSM-IV) diagnostic 
classification for eating disorders: anorexia nervosa, bulimia 
nervosa, and EDNOS.29 EDNOS contains incomplete forms of 
anorexia nervosa or bulimia nervosa, as well as binge eating 
disorder. To enable classification as binge eating disorder with 
more certainty, we added 1 question from the Structured Clini-
cal Interview for DSM-IV to our SCAN interview. Section 8 
of the SCAN assesses physical functions such as changes in 
BMI over time. Section 9 assesses various symptoms of eating 
disorders, as well as the interference with daily activities due 
to these symptoms. We added section 6 and 7 from the SCAN, 
which cover depressive symptomatology, in order to assess the 
influence of mood symptoms on eating behavior.
In study II, besides the SCAN, subjects completed the Eating 
Disorders Examination-Questionnaire (EDE-Q 4th edition).30 
The EDE-Q is a self-report version of the Eating Disorder Ex-
amination.31 It is a 36-item scale that assesses features of eating 
disorders, generating 4 subscale scores: dietary restraint, eating 
concern, weight concern, and shape concern. Respondents rate 
the items on a 7-point scale, indicating the number of days out 
of the previous 28 in which specific behaviors and attitudes oc-
curred. The EDE-Q has received psychometric support, includ-
ing adequate test-retest reliability32,33 and a good convergence 
with the EDE-interview.30,34,35 Disordered eating was defined 
when subjects scored 4 or greater on either the weight concern 
or the shape concern subscale, had a mean global score of 4 or 
greater, or had more than 1 episode of self-induced vomiting, 
binging with loss of control or diuretic or laxative use over the 
last 4 weeks.24,36
statistical analysis
All data are presented as mean ± standard deviation. Mean 
item scores and item frequencies were compared between 
groups using student t-test and Fisher exact test, respectively. 
To obtain DSM-IV diagnostic classifications from the SCAN 
interview, we used the software algorithm written by C.R. in 
SAS version 8, in consultation with and after approval of the 
World Health Organization SCAN workgroup. All other sta-
tistical comparisons were done using SPSS version 14 (SPSS, 
Inc., Chicago, IL). Significance level was set at P = 0.05.
results
Demographic and clinical Variables
In Table 1, the demographic characteristics of the partici-
pants are listed. In both studies, patients and controls were well 
matched for sex and age. On average, patients had narcolepsy 
symptoms for approximately 20 years at the time of study. Fif-
ty-two percent of patients used stimulant medication (modafinil 
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or methylphenidate), 12% used sodium oxybate, and 43% used 
antidepressants for cataplexy.
In study I, we again confirmed that patients with narcolepsy 
are overweight: there was a significant difference in BMI be-
tween patients (27.8 ± 5.7) and controls (24.6 ± 3.3, P = 0.001). 
BMI was not influenced by sex. In study II, patients and con-
trols were well matched for BMI.
symptoms of eating Disorders
The percentages of participants scoring positive on the vari-
ous items of the SCAN are listed in Table 2. In study I, patients 
with narcolepsy scored significantly higher on all items, except 
for “actions to lose weight through purgation.” About half of 
the patients reported a persistent craving for food, experienced 
an earlier episode of overeating, and experienced binge eating. 
Twenty-five percent of patients even reported binging twice a 
week or more often. The majority of patients reported a dread 
of becoming fat, a self-perception of fatness, or both. Patients 
also took more measures for weight control, such as the avoid-
ance of fattening foods or trying to lose weight through self-
restriction. No endocrine disturbances were reported, such as 
delayed onset of puberty or amenorrhea.
Female patients showed significantly higher scores than 
males on the following items: dread of becoming fat (78% vs 
43%, P = 0.001) and dread of getting too fat in spite of crav-
ing (44% vs 15%, P = 0.02). Furthermore, women more often 
reported a certain level of interference of symptoms of eating 
disorders in daily life (72% vs 43%, P = 0.013).
In study II, BMI-matched controls also reported symptoms of 
eating disorders, such as a self-perception of fatness and mea-
sures for weight control (Table 2). However, even when com-
pared with BMI-matched controls, patients with narcolepsy had 
a significantly increased frequency of episodes of overeating, 
binge eating, and a persistent craving for food. Furthermore, 
within the patient group, there was no difference in BMI be-
tween subjects who reported binge eating and those who did 
not. There were also no significant correlations between BMI 
Table 1—Demographic and Clinical Characteristics
  Study I   Study II
 Patients Controls P Patients Controls P
No. 60 120  32 32 
Age, y 43.5 ± 15.6 43.5 ± 15.4 0.97 40.4 ± 15.1 42.2 ± 11.7 0.079
Males, no. 28 (47%) 56 (47%) 1.00 11 (34%) 11 (34%) 1.00
BMI, kg/m2 27.8 ± 5.7 24.6 ± 3.3 0.001 27.6 ± 7.1 27.6 ± 5.0 0.43
Age at onset, y 20.1 ± 9.2   19.7 ± 7.6  
Age at diagnosis, y 30.6 ± 11.6   28.2 ± 10.8  
Duration of symptoms, y 23.9 ± 15.8   20.4 ± 13.0  
Duration since diagnosis, y 10.5 ± 11.0   11.10 ± 9.4  
Data are expressed as mean ± SD unless otherwise indicated. BMI refers to body mass index.
Table 2—SCAN Section 9 (Item Level Symptoms of Eating Disorders)
 Study I Study II
  Patients Controls P Patients Controls P
No. 60 120  32 32 
Dread of becoming fat 62% 8% <0.001 78% 31% <0.001
Earlier episode of undereating 13% 5% 0.074 22% 16% 0.75
Irresistible and persistent craving for food 67% 5% <0.001  66% 13% <0.001
Earlier episode of overeating 42% 5% <0.001 50% 22% 0.036
Self-perception of fatness w/ intrusive dread of becoming too fat 33% 1% <0.001 38% 22% 0.274
Imposes low weight threshold 5% 0% 0.036 13% 3% 0.355
Avoidance of fattening foods 45% 3% <0.001 53% 34% 0.207
Actions to lose weight through self restriction 42% 2% <0.001 43% 13% 0.011
Actions to lose weight through purgation 3% 1% 0.258 9% 0% 0.24
Binge eating w/ sense of lack of control      
 None 45% 99% <0.001* 31% 78% 0.002*
 Binges but retains control 12% 0%  13% 13% 
 Binges infrequently w/ feeling of loss of control 18% 1%  28% 9% 
 Binges twice a week, w/ a feeling of lack of control 20% 0%  16% 0% 
 Binges more frequently w/ a feeling of loss of control 5% 0%  9% 0% 
Dread of getting too fat in spite of craving 30% 0% <0.001  28% 0% 0.002
Actions to correct binging through purgation 7% 0% 0.012 6% 3% 1.000
Restrictive actions to correct binging 18% 0% <0.001 25% 0% 0.005
*χ2 test. SCAN refers to Schedules for Clinical Assessment in Neuropsychiatry.
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between treated and untreated patients and, separately, between 
patients with or without the use of antidepressants or stimulants. 
The results are shown in Table 4. Interestingly, medication use 
did not increase BMI. Treated patients even tended toward a 
lower BMI. Furthermore, medication use did not influence the 
prevalence of symptoms and diagnoses of eating disorders, ex-
cept for a trend toward more irresistible craving in the patients 
using antidepressants. Furthermore, the patients who received 
treatment reported a significantly higher level of interference 
with activities due to eating problems.
Mood disorders may interact with the presence of diagno-
ses and symptoms of eating disorders. The number of patients 
fulfilling the criteria for depression or bipolar disorder was too 
small to make any comparisons. We therefore compared patients 
with and without the SCAN-symptom “depressive mood” and 
“anhedonia” on BMI, key symptoms of eating disorders, and 
diagnoses of eating disorders. We found no effect of these mood 
symptoms, except for a higher prevalence of binge eating with 
lack of control (with depressive mood: 67% vs 33%, P = 0.024; 
with anhedonia: 75% vs 32%, P = 0.004) and a higher number 
of EDNOS diagnoses (with depressive mood: 39% vs 5%, P = 
0.002; with anhedonia 38% vs 7%, P = 0.008). So, especially 
for the diagnosis EDNOS, there seems to be a relation with the 
presence of depressed mood and anhedonia.
eDe-Q results
Results from the EDE-Q auto-questionnaire are presented in 
Tables 5 and 6. Several measures of attitudes in eating behavior 
(dietary restraint, eating and weight concern) were significantly 
and the EDE-Q subscales on objective and subjective bulimic 
episodes.
Symptoms of eating disorders posed a clear interference with 
daytime activities in patients. More than 30% of patients report-
ed moderate to severe (and incapacitating) interference with ac-
tivities, compared with 1% of controls in the general population 
and 6% in BMI-matched controls (P < 0.001).
DsM-IV classification of eating Disorders
Using the SCAN data, subjects were classified in the DSM-
IV eating disorders diagnoses (Table 3). In total, 23.3% of 
the patients fulfilled the criteria for a clinical eating disorder, 
against none of the control subjects. Only 1 patient was classi-
fied as having anorexia nervosa. Four patients (6.7%) fulfilled 
the criteria of bulimia nervosa. Nine patients(15%) were classi-
fied as EDNOS. Within this category, 2 patients were subthresh-
old anorexia nervosa cases (having all criteria except amenor-
rhea); 1 patient had subthreshold bulimia nervosa (having all 
criteria, but binge frequency was less than twice a week). Six 
patients met the criteria for binge eating disorder, 5 of whom 
were subthreshold because of missing the DSM-IV criterion of 
“marked distress regarding binge eating.” In study II, the results 
regarding DSM-IV eating disorders diagnoses were essentially 
the same as in study I.
At the time of study, 17 out of 60 patients (28.3%) did not 
receive treatment for their narcolepsy, with stimulants, sodium 
oxybate, or antidepressants. Only 6 control subjects (5%) used 
antidepressant drugs. We compared BMI, diagnoses of eating 
disorders, and the most salient symptoms of eating disorders 
Table 3—DSM-IV Eating Disorders Classification
  Study I   Study II
 Patients Controls P Patients Controls P
No. 60 120  32 32 
Anorexia 1 (1.7%) 0 (0%) 0.33 1 (3%) 0 (0%) 1.00
Bulimia  4 (6.7%) 0 (0%) 0.012 2 (6.3%) 0 (0%) 0.49
Eating Disorder NOS 9 (15%) 0 (0%) <0.001 8 (25%) 0 (0%) 0.005
DSM-IV refers to Diagnostic and Statistical Manual of Mental Disorders, 4th ed; NOS, not otherwise specified.
Table 4—Influence of Medication on BMI, Key Eating Disorders Symptoms, and Eating Disorders Diagnoses
 Med No med P AD no AD P Stim No Stim P
N 43 17  26 34  28 32 
BMI 26.8 30.2 0.09 26.9 28.4 0.31 26.6 28.8 0.13
Dread of becoming fat 61% 65% 1.0 62% 62% 1.0 61% 63% 1.0
Irresistible and persistent craving for food  72% 53% 0.23 81% 56% 0.06 71% 63% 0.59
Earlier episode of overeating 37% 53% 0.38 35% 47% 0.43 39% 44% 0.80
Actions to lose weight through purgation 2% 6% 0.49 4% 3% 1.0 0% 6% 0.49
Binge eating w/ sense of lack of control 40% 53% 0.40 42% 44% 1.0 39% 47% 0.61
Interference with activities due to eating problems 33% 24% 0.55 46% 18% 0.02 29% 31% 1.0
Diagnosis anorexia nervosa 2% 0% 1.0 4% 0% 0.4 4% 0% 0.047
Diagnosis bulimia nervosa 7% 6% 1.0 4% 9% 0.63 7% 6% 1.0
Diagnosis EDNOS 9% 29% 0.1 12% 18% 0.72 11% 19% 0.48
BMI refers to body mass index; Med, medication; AD, antidepressants; Stim, stimulants; EDNOS, eating disorder not otherwise specified.
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vious studies that found very low prevalences, even in selected 
populations that would be at higher risk, such as young females 
(in the range of 0.7% for anorexia nervosa to 1% to 2% for buli-
mia nervosa).37 The prevalence of EDNOS has been established 
less extensively; a recent study of 2018 Portuguese young fe-
males found a prevalence of not more than 2.4%.38
Interestingly, the effect of the various medications used for 
narcolepsy had no clear influence on the prevalence of diag-
noses and symptoms of eating disorders, nor on BMI. In fact, 
medication use tended to be associated with a lower BMI. There 
was as slight trend toward more craving in patients using anti-
depressants, and these patients also report more interference in 
activities due to eating problems. Regarding the influence of 
symptoms of mood disorders, patients with depressive mood 
and/or anhedonia had a higher number of EDNOS diagnoses, 
as well as binge eating with lack of control. However, in our 
cross-sectional study design, it is not possible to decipher the 
“direction” of this correlation. Further (longitudinal) studies 
may shed light on this issue.
The few other reports on eating disorder symptomatology 
in narcolepsy also found an emphasis on binge eating.3,12 Re-
cently, Chabas et al reported that half of 6 typical and 7 atypical 
patients with narcolepsy could be classified as EDNOS, with 
features of bulimia nervosa.12 Diagnosis of EDNOS seems to 
have been made on a rough exclusion of anorexia and bulimia 
nervosa without precise criteria, however.12 Because of the 
small sample size, the influence of sex on eating behavior could 
not be assessed. In our study, we did not find a difference in 
binging behavior between men and women. However, women 
more often reported a dread of becoming fat and a higher level 
of interference in activities. So, despite binging to the same ex-
tent, women are more worried about their eating behavior.
Previous studies into binge eating disorder have shown a 
positive correlation between binge eating and obesity.39 Chabas 
et al also showed a trend toward more pronounced symptoms 
in the narcoleptics who were overweight, compared with those 
with a normal BMI.12 However, in our study, we could not es-
tablish a relationship between BMI and binge eating.
In fact, the relationship between symptoms of eating disor-
ders and BMI may be the other way: a higher BMI has been 
higher in patients compared with BMI-matched controls. Ob-
jective bulimic episodes showed a trend to occur more often in 
patients than in controls. However, the frequency of subjective 
bulimic episodes was not significantly higher.
Female patients scored significantly higher than males on the 
dietary restraint (9.5 ± 8.4 vs 5.2 ± 3.1, P = 0.046) and eating 
concern (7.3 ± 9.1 vs 1.5 ± 1.5, P = 0.011) subscales. Weight 
and shape concern showed a trend toward a higher score in 
women (11.0 ± 7.4 vs 6.2 ± 5.5, P = 0.068; 20.1 ± 12.8 vs 11.1 
± 12.2, P = 0.064 respectively). There were no differences in 
the frequency of objective and subjective binges between men 
and women.
Disordered eating behavior can be assessed using cut-off 
criteria for the various EDE-Q subscales (Table 6).24,36 Disor-
dered eating is a measure of pathogenic eating behavior, at risk 
for developing an eating disorder.24 Our analysis yielded a high 
degree of disordered eating in narcoleptic patients, even when 
compared with BMI-matched controls, corroborating the re-
sults from the SCAN.
DIscussIoN
In this study, we showed that a considerable number of pa-
tients with narcolepsy-cataplexy display various symptoms of 
eating disorders, with an emphasis on a craving for food and 
binge eating behavior. In almost a quarter of patients, it was 
even possible to make a formal DSM-IV eating disorder clas-
sification. Many patients reported a dread of becoming fat, and 
the eating problems posed a clear interference with activities in 
more than one third of our cohort. Eating disorders seem to be 
an integral part of the narcolepsy phenotype and not only due to 
the increase in BMI, as narcoleptic patients scored significantly 
higher on various items of both the SCAN and EDE-Q when 
compared with BMI-matched healthy controls.
On the symptom level, narcoleptics reported irresistible and 
persistent craving for food, binge eating with lack of control, 
and restrictive actions to correct binging. However, there was 
no single specific eating disorder classification within the pa-
tient group: bulimia nervosa (4/60), anorexia nervosa (1/60), 
and EDNOS (9/60) were all present. Within the EDNOS group, 
however, 6 of 9 patients could indeed be categorized into binge 
eating disorder, whereas the others had subthreshold bulimia 
or anorexia. These prevalence numbers are clearly higher than 
those in the overall population. In our control cohort, no formal 
eating disorders could be diagnosed, and this is in line with pre-
Table 5—EDE-Q Subscale Scores in Patients Versus BMI-
Matched Controls
 Patients Controls P
No. 32 32 
Dietary restraint 8.0 ± 7.3 2.6 ± 3.6 <0.001
Eating concern 5.2 ± 7.8 1.1 ± 2.5 0.009
Weight concern 9.3 ± 7.1 5.8 ± 5.6 0.031
Shape concern 17.0 ± 13.1 11.1 ± 11.8 0.067
Objective bulimic episodes 2.0 ± 5.0 0.2 ± 0.8 0.057
Subjective bulimic episodes 1.1 ± 4.5 0.4 ± 1.8  0.40
EDE-Q refers to the Eating Disorders Examination-Questionnaire; 
BMI, body mass index.
Table 6—Disordered Eating Behaviors in Patients Versus BMI-
Matched Controls
 Patients Controls P
No. 32 32 
Score ≥ 4 dietary restraint 62.5% 21.9% 0.002
Score ≥ 4 eating concern 29% 9.7% 0.11
Score ≥ 4 weight concern 78.1% 51.6% 0.036
Score ≥ 4 shape concern 90.6% 64.5% 0.016
Mean global score ≥4 82.8% 50% 0.012
> 1 episode of self
  induced vomiting 3.2% 0% 0.49
> 1 episode of self induced
  binging with lack of control 29% 6.3% 0.022
>1 episode of diuretic use  0% 0% *
>1 episode of laxative use 0% 0% *
BMI refers to body mass index.
*No statistics computed because both patients and controls = 0
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lepsy with cataplexy. Hypocretin-1 levels were known in only a 
small number of subjects, so we were not able to directly assess 
the influence of hypocretin deficiency. However, it is known 
that in patients with sporadic and clear-cut cataplexy, more than 
90% of subjects are hypocretin-1 deficient.9 Although we used 
validated instruments to assess symptoms, we did not system-
atically collect data to measure the timing of binges and crav-
ing for food. We were thus unable to assess the presence of the 
night eating syndrome. Six out of 32 patients in study II spon-
taneously mentioned binging at night; other patients reported 
that, with a build-up of sleep pressure throughout the day, the 
resistance against binging diminished. Future studies should 
include a formal assessment of the night eating syndrome and 
address circadian, sleep homeostatic, and mood influences on 
the frequency and severity of binging. Furthermore, the preva-
lence of the metabolic syndrome and other cardiovascular and 
endocrine complications should be assessed in narcolepsy. Fi-
nally, it would be of great interest to study the direct effect of 
hypocretin disturbances and associated endocrine changes in 
narcolepsy, for example in leptin or ghrelin levels.
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